Q-Line Biotech (NSE:QLINE) Inventory Turnover: 1.86 (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Inventory Turnover?

Q-Line Biotech NSE:QLINE -5.15% 12 Inventory Turnover is 1.86 as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Q-Line Biotech's Cost of Goods Sold for the six months ended in Mar. 2025 was ₹1,815 Mil. Q-Line Biotech's Average Total Inventories for the quarter that ended in Mar. 2025 was ₹977 Mil. Q-Line Biotech's Inventory Turnover for the quarter that ended in Mar. 2025 was 1.86.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Q-Line Biotech's Days Inventory for the six months ended in Mar. 2025 was 98.29.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Q-Line Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.31.

Q-Line Biotech  (NSE:QLINE) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Q-Line Biotech's Days Inventory for the six months ended in Mar. 2025 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2025 )/Cost of Goods Sold (Q: Mar. 2025 )*Days in Period
=977.272/1814.574*365 / 2
=98.29

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Q-Line Biotech's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=977.272 / 3137.804
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Q-Line Biotech Inventory Turnover Related Terms

Q-Line Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Inventory Turnover Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Inventory Turnover
2.40 1.62 1.86

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Inventory Turnover 2.40 1.62 1.86
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Inventory Turnover Calculation

Q-Line Biotech's Inventory Turnover for the fiscal year that ended in Mar. 2025 is calculated as

Inventory Turnover (A: Mar. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Mar. 2025 ) / ((Total Inventories (A: Mar. 2024 ) + Total Inventories (A: Mar. 2025 )) / count )
=1814.574 / ((1052.41 + 902.134) / 2 )
=1814.574 / 977.272
=1.86

Q-Line Biotech's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover (Q: Mar. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2025 ) / ((Total Inventories (Q: Mar. 2024 ) + Total Inventories (Q: Mar. 2025 )) / count )
=1814.574 / ((1052.41 + 902.134) / 2 )
=1814.574 / 977.272
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 1.86 mean?
Q-Line Biotech (NSE:QLINE) has a Inventory Turnover of 1.86 as of Mar. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Inventory Turnover too high?
Q-Line Biotech's current Inventory Turnover is 1.86. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Inventory Turnover compare to ABT and SYK?
Q-Line Biotech's Inventory Turnover of 1.86 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Medical Devices & Instruments company?
A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Inventory Turnover is 1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Inventory Turnover of 1.86. The current Inventory Turnover is 1.86. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Inventory Turnover is 1.86 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price